GLP-1 Medications and Testosterone in Men: What the Evidence Shows

Does semaglutide increase testosterone in men? How GLP-1-mediated weight loss affects male hormones, low T symptoms, and sexual function. April 2026.

Sarah ChenLead Health Editor

Updated April 14, 2026

6 questions

Quick Answers

Click any question to expand the answer

GLP-1 medications indirectly increase testosterone in men with obesity by reducing adipose tissue, which is the primary site of aromatase activity — the enzyme that converts testosterone to estrogen. Significant weight loss from GLP-1 treatment reduces estrogen conversion and increases free and total testosterone. Clinical studies show meaningful testosterone increases with GLP-1-mediated weight loss: men losing 15–20% of body weight commonly see testosterone increases of 100–200 ng/dL or more.

Obesity lowers testosterone through multiple mechanisms: (1) Aromatase enzyme in adipose tissue converts testosterone to estradiol (estrogen); (2) Excess estrogen suppresses the hypothalamic-pituitary axis, reducing LH and FSH secretion, which reduces testicular testosterone production; (3) Insulin resistance impairs Leydig cell function in the testes; (4) Inflammatory cytokines from adipose tissue suppress testosterone synthesis. The result is a vicious cycle: low testosterone promotes fat accumulation, which further suppresses testosterone.

For men with low testosterone caused primarily by obesity (secondary hypogonadism from adiposity), GLP-1-mediated weight loss can restore testosterone to normal ranges without TRT. This is clinically important because TRT in hypogonadal men with obesity carries risks (polycythemia, exogenous testosterone suppression of the HPT axis). Guidelines increasingly recommend weight loss as first-line for obesity-related hypogonadism before initiating TRT. Men who normalize testosterone through weight loss avoid lifelong TRT dependence.

Yes — indirectly and in some cases directly. The improvements come through: (1) Testosterone increase from weight loss improves libido and erectile function; (2) Improved vascular health (cardiovascular benefits of GLP-1) improves blood flow — erectile function is highly dependent on vascular health; (3) Reduced visceral fat improves hormonal profile overall; (4) Some evidence of direct GLP-1 receptor effects on penile vasculature. Clinical improvements in erectile function are reported by a meaningful proportion of men on GLP-1 medications.

The testosterone increase depends on starting testosterone level, degree of obesity, and amount of weight lost. Rough clinical estimates: men with BMI ≥35 and low testosterone (200–300 ng/dL) who lose 15–20% of body weight may see increases of 100–250 ng/dL — often moving from hypogonadal into low-normal or normal range. Men with less severe obesity and milder testosterone suppression may see smaller but still meaningful increases. Testosterone response to weight loss is highly individual.

It's worth discussing with your provider. Baseline testosterone testing (total T, free T, LH, FSH, SHBG) before starting GLP-1 treatment: (1) Establishes whether low testosterone is present and how severe; (2) Allows monitoring of improvement with weight loss; (3) Helps distinguish obesity-related secondary hypogonadism from primary hypogonadism (testicular failure), which does not respond to weight loss; (4) Informs whether TRT should be concurrent with or deferred until after GLP-1 treatment.

In-Depth Guide

GLP-1 Medications and Testosterone in Men

Obesity and low testosterone are closely intertwined in men — and GLP-1 medications, by treating obesity directly, can meaningfully improve male hormonal health. This is one of the most underappreciated benefits of GLP-1 treatment in men.

The Obesity-Testosterone Loop

Excess body fat
        ↓
Increased aromatase activity → Testosterone → Estradiol conversion
        ↓
Elevated estrogen + reduced testosterone
        ↓
Hypothalamic-pituitary suppression (less LH/FSH)
        ↓
Reduced testicular testosterone production
        ↓
Low testosterone → promotes further fat accumulation → loop continues

GLP-1 medications break this cycle at the top by reducing adipose tissue mass — the source of aromatase activity.

What Happens to Testosterone with GLP-1 Treatment

Weight Lost	Expected Testosterone Effect
5–9% body weight	Modest improvement (~50–100 ng/dL increase)
10–14% body weight	Meaningful improvement (~100–150 ng/dL); may cross into normal range
15–20%+ body weight	Substantial improvement (~150–250+ ng/dL); normalization common in obesity-related hypogonadism

Clinical studies:

Men in STEP-1 (semaglutide 2.4mg) with obesity who lost substantial weight showed significant testosterone increases correlated with weight loss
SURMOUNT-1 (tirzepatide) similarly showed androgenic improvements in male participants
The relationship is strongest in men with BMI ≥35 and confirmed low testosterone at baseline

This distinction determines whether weight loss will restore testosterone:

Type	Cause	LH/FSH	TRT Response	GLP-1/Weight Loss Response
Secondary (functional) hypogonadism	Obesity, insulin resistance	Low or normal	Yes	Strong — root cause addressed
Primary hypogonadism	Testicular failure (Klinefelter's, prior injury, chemo)	High	Yes	Weak — testis cannot respond
Aging-related decline	Normal aging	Borderline	Moderate	Moderate — partial improvement

Men with obesity-related secondary hypogonadism — the largest group of men with low testosterone — are the ideal candidates for a GLP-1-first approach to testosterone restoration.

GLP-1 vs TRT: A Decision Framework

Scenario	Recommendation
Obese man, low T, no prior TRT	GLP-1 first — may restore T without TRT
Obese man, very low T (<150 ng/dL), symptomatic	Discuss concurrent TRT + GLP-1 with urologist or endocrinologist
Already on TRT, wants to optimize	GLP-1 + weight loss may allow TRT dose reduction
Primary hypogonadism (high LH/FSH)	TRT likely needed; GLP-1 still valuable for metabolic benefits
Normal weight, isolated low T	GLP-1 not indicated for T; evaluate other causes

Sexual Function Improvements Beyond Testosterone

Men on GLP-1 medications report improvements in sexual function that extend beyond testosterone:

Vascular improvement — erectile function is directly dependent on endothelial health and blood flow; GLP-1 cardiovascular benefits improve penile vasculature
Energy and mood — testosterone and weight loss together reduce fatigue; improved energy supports libido
Self-image — significant weight loss improves body confidence, which has documented effects on sexual function
Reduced sleep apnea — OSA severely disrupts sleep and is associated with low testosterone; OSA improvement from GLP-1 further supports hormonal recovery

Monitoring for Men on GLP-1 Medications

Test	Baseline	6 Months	12 Months
Total testosterone	Yes	Yes	Yes
Free testosterone + SHBG	Yes	Optional	Yes
LH / FSH	Yes (to classify type)	—	If not normalizing
Estradiol (E2)	Optional	Optional	—
CBC (if on TRT also)	If TRT	Every 6 months	Every 6 months

Best GLP-1 for Men — men-focused GLP-1 programs
GLP-1 Muscle Loss FAQ — preserving lean mass (especially important for men)
GLP-1 Mental Health FAQ — mood and energy effects
Best GLP-1 with Coaching — programs with comprehensive metabolic support

More GLP-1 FAQs

Explore other common questions about GLP-1 medications

Ready to Find Your Provider?

Take our quiz to get personalized provider recommendations based on your needs.

Find Your Match Compare Medications

GLP-1 Medications and Testosterone in Men: What the Evidence Shows

Quick Answers

In-Depth Guide

GLP-1 Medications and Testosterone in Men

The Obesity-Testosterone Loop

What Happens to Testosterone with GLP-1 Treatment

Distinguishing Obesity-Related vs Primary Hypogonadism

GLP-1 vs TRT: A Decision Framework

Sexual Function Improvements Beyond Testosterone

Monitoring for Men on GLP-1 Medications

Related Resources

More GLP-1 FAQs

Compounded vs Brand-Name GLP-1 FAQ: Safety, Legality, and Key Differences

GLP-1 Medications and Addiction: Alcohol, Nicotine, and Opioid Use Disorder Research

GLP-1 Medications and ADHD: Dopamine Overlap, Stimulant Interactions, and Appetite Effects

GLP-1 and Alcohol: Can You Drink on Semaglutide or Tirzepatide?

GLP-1 Medications and Appetite Suppression: When It's Too Much

GLP-1 Medications and Athletic Performance: What Athletes and Active Patients Need to Know

GLP-1 vs Bariatric Surgery: Efficacy, Risks, Cost, and Who Should Choose Which

GLP-1 Medications and Birth Control: What You Need to Know

Body Recomposition on GLP-1: Losing Fat While Preserving Muscle

Cagrisema: The GLP-1 + Amylin Combination That May Surpass Tirzepatide

GLP-1 Medications and Cardiovascular Risk: Beyond the SELECT Trial

GLP-1 Medications for Adolescents: FDA Approval, Safety, and What Parents Need to Know

GLP-1 Medications and Brain Health: Cognition, Dementia Risk, and Neurological Effects

Compounding Pharmacies for GLP-1 Medications: 503A vs 503B, Safety, and Legal Status

Compounded GLP-1 Status April 2026: What's Legal, What's Not, and What Changed

GLP-1 Medications and Constipation: Causes and Relief

Is GLP-1 Worth the Cost? Cost-Effectiveness Explained

GLP-1 Cost & Insurance FAQ: What You'll Actually Pay for Semaglutide, Tirzepatide & More

GLP-1 Medications and Alcohol Cravings: What the Research Shows

Can You Get Semaglutide at CVS or Walgreens? GLP-1 Pharmacy FAQ

GLP-1 Medications and Dental Health: Dry Mouth, 'Ozempic Mouth,' and Oral Care

GLP-1 for Diabetes vs Weight Loss: Key Differences Explained

What to Eat (and Avoid) on Semaglutide — Diet FAQ

GLP-1 Dosing Schedule: When and How to Take Your Medication

GLP-1 Medication Drug Interactions: What to Watch For

GLP-1 Eligibility & Access FAQ: Do You Qualify for Semaglutide or Tirzepatide?

Can I Get a GLP-1 Prescription? BMI and Eligibility FAQ

Exercise on GLP-1 Medications: What to Do, When to Start, and How Much

GLP-1 Medications and Fatty Liver Disease (MASH/NAFLD): What to Know

First Week on GLP-1: What to Expect (Day by Day)

Food Noise and GLP-1 Medications: What It Is and Why It Goes Quiet

GLP-1 Medications for PCOS: Benefits, Evidence, and What to Expect

GLP-1 for Specific Conditions: PCOS, Type 2 Diabetes, Metabolic Syndrome & More

GLP-1 Medications and Gallbladder: Gallstone Risk FAQ

GLP-1 Medications and Gout: Uric Acid, Flares, and What to Expect

GLP-1 Medications and the Gut Microbiome: What the Research Shows

Does Semaglutide Cause Hair Loss? GLP-1 and Hair Loss FAQ

Headaches on GLP-1 Medications: Causes, Duration, and What Helps

GLP-1 Medications and Heart Disease: Benefits and Considerations

GLP-1 Medications and Heart Failure: STEP-HFpEF Results and What They Mean

GLP-1 Medications and Hidradenitis Suppurativa: Inflammation, Obesity, and Emerging Evidence

GLP-1 Medications and Hypoglycemia: Who Is at Risk and What to Do

GLP-1 Medications and Systemic Inflammation: Beyond Weight Loss

GLP-1 Injection Sites: Where to Inject, How to Rotate, and What to Avoid

How to Inject Semaglutide: Step-by-Step Guide and FAQ

GLP-1 Insurance Denial: How to Appeal and Get Coverage

GLP-1 Prior Authorization: How to Get Your Insurance to Cover Ozempic or Wegovy

GLP-1 Medications and Joint Pain: What Weight Loss Does to Arthritis and Joints

GLP-1 Medications and Kidney Disease: What Patients Need to Know

Lab Tests Before and During GLP-1 Medication Treatment

GLP-1 Long-Term Safety: What We Know After 5+ Years of Data

GLP-1 Maintenance Dose: What Happens After You Reach Your Goal

GLP-1 Medications and Male Fertility: Sperm Quality, Testosterone, and What Men Should Know

GLP-1 Medication Storage: Temperature, Cold Chain, and What to Do If Your Pen Gets Warm

GLP-1 Medications Compared: Semaglutide vs Tirzepatide vs Liraglutide vs Orforglipron

GLP-1 Medications During Menopause and Perimenopause: What Changes

GLP-1 Medications and Mental Health: Mood, Depression, and Anxiety

GLP-1 Medications and Metabolic Syndrome: Addressing All Five Criteria

GLP-1 Medications and Muscle Loss: What the Research Shows

GLP-1 Nausea: How to Manage It and When It Goes Away

GLP-1 Injections and Needle Phobia: How to Manage Fear and What Alternatives Exist

GLP-1 Non-Responders: Why Some People Don't Lose Weight and What to Do

GLP-1 and Obesity as a Disease: Why It's Not About Willpower

GLP-1 Medications for Adults Over 65: Benefits, Risks, and Special Considerations

Orforglipron: The First True Oral GLP-1 Pill Without Special Handling

GLP-1 Medications and Pancreatitis: Risk FAQ

GLP-1 Patient Advocacy Guide: Getting Your Prescription, Fighting Denials, and Talking to Your Doctor

GLP-1 Pen vs Vial: Brand-Name vs Compounded Delivery Compared